O. Lambotte, F. Boufassa, Y. Madec, A. Nguyen, C. Goujard et al., HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.41, issue.7, pp.1053-1059, 2005.

B. D. Walker, Elite control of HIV Infection: implications for vaccines and treatment, Top HIV Med Publ Int AIDS Soc USA, vol.15, issue.4, pp.134-140, 2007.

C. Lécuroux, A. Sáez-cirión, I. Girault, P. Versmisse, F. Boufassa et al.,

H. Both, 57 and plasma HIV RNA levels contribute to the HIV-specific CD8+ T cell response in HIV controllers, J Virol, vol.88, issue.1, pp.176-87, 2014.

A. Sáez-cirión, C. Hamimi, A. Bergamaschi, A. David, P. Versmisse et al., Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers, Blood, vol.118, issue.4, pp.955-64, 2011.

D. Benati, M. Galperin, O. Lambotte, S. Gras, A. Lim et al., Public T cell receptors confer high-avidity CD4 responses to HIV controllers, J Clin Invest, vol.126, issue.6, pp.2093-108, 201601.
URL : https://hal.archives-ouvertes.fr/pasteur-01319968

H. F. Günthard, M. S. Saag, C. A. Benson, C. Del-rio, J. J. Eron et al., Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel, JAMA, vol.316, issue.2, pp.191-210, 2016.

M. S. Saag, C. A. Benson, R. T. Gandhi, J. F. Hoy, R. J. Landovitz et al., Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults, Recommendations of the International Antiviral Society-USA Panel. JAMA, vol.320, issue.4, pp.379-96, 2018.

D. Gurdasani, L. Iles, D. G. Dillon, E. H. Young, A. D. Olson et al., A systematic review of definitions of extreme phenotypes of HIV control and progression, AIDS Lond Engl, vol.28, issue.2, pp.149-62, 2014.

Y. Madec, F. Boufassa, K. Porter, L. Meyer, and . Cascade-collaboration, Spontaneous control of viral load and CD4 cell count progression among HIV-1 seroconverters, AIDS Lond Engl, vol.19, issue.17, pp.2001-2008, 2005.

M. Altfeld, T. M. Allen, X. G. Yu, M. N. Johnston, D. Agrawal et al.,

, superinfection despite broad CD8+ T-cell responses containing replication of the primary virus, Nature, vol.420, issue.6914, pp.434-443, 2002.

J. R. Bailey, H. Zhang, B. W. Wegweiser, H. Yang, L. Herrera et al., Evolution of HIV-1 in an HLA-B*57-positive patient during virologic escape, J Infect Dis, vol.196, issue.1, pp.50-55, 2007.

F. Chereau, Y. Madec, C. Sabin, N. Obel, E. Ruiz-mateos et al., Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllers, PloS One, vol.12, issue.4, p.173893, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01522520

O. O. Yang, W. G. Cumberland, R. Escobar, D. Liao, and K. W. Chew, Demographics and natural history of HIV-1-infected spontaneous controllers of viremia, AIDS Lond Engl, vol.31, issue.8, pp.1091-1099, 201715.

Y. Madec, F. Boufassa, K. Porter, M. Prins, C. Sabin et al., Natural history of HIV-control since seroconversion, AIDS Lond Engl, vol.27, issue.15, pp.2451-60, 2013.

H. Hatano, M. Somsouk, E. Sinclair, K. Harvill, L. Gilman et al., Comparison of HIV DNA and RNA in gut-associated lymphoid tissue of HIV-infected controllers and noncontrollers, AIDS Lond Engl, vol.27, issue.14, pp.2255-60, 2013.

E. A. Boritz, S. Darko, L. Swaszek, G. Wolf, D. Wells et al., Multiple Origins of Virus Persistence during Natural Control of HIV Infection, Cell, vol.166, issue.4, pp.1004-1019, 2016.

M. Chaix, F. Boufassa, C. Meyzer, M. Leruez-ville, N. Mahjoub et al., Detectable HIV-RNA in semen of HIV controllers, PloS One, vol.12, issue.8, p.183376, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01581747

T. C. Quinn, M. J. Wawer, N. Sewankambo, D. Serwadda, C. Li et al., Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group, N Engl J Med, vol.342, issue.13, pp.921-930, 2000.

C. Mussini, P. Lorenzini, A. Cozzi-lepri, G. Lapadula, G. Marchetti et al., CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study, Lancet HIV, vol.2, issue.3, pp.98-106, 2015.

F. Boufassa, A. Saez-cirion, J. Lechenadec, D. Zucman, V. Avettand-fenoel et al., CD4 dynamics over a 15 year-period among HIV controllers enrolled in the ANRS French observatory, PloS One, vol.6, issue.4, p.18726, 2011.
URL : https://hal.archives-ouvertes.fr/pasteur-01420582

K. C. Groves, D. F. Bibby, D. A. Clark, A. Isaksen, J. R. Deayton et al., Disease Progression in HIV-1-Infected Viremic Controllers, J Acquir Immune Defic Syndr, vol.61, issue.4, pp.407-423, 1999.

J. F. Okulicz, V. C. Marconi, M. L. Landrum, S. Wegner, A. Weintrob et al., Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study, J Infect Dis, issue.11, pp.1714-1737, 0200.

A. Leon, I. Perez, E. Ruiz-mateos, J. M. Benito, M. Leal et al., Rate and predictors of progression in elite and viremic HIV-1 controllers, AIDS Lond Engl, vol.30, issue.8, pp.1209-1229, 2016.

N. Noel, N. Lerolle, C. Lécuroux, C. Goujard, A. Venet et al., Immunologic and Virologic Progression in HIV Controllers: The Role of Viral "Blips" and Immune Activation in the ANRS CO21 CODEX Study, PloS One, vol.10, issue.7, p.131922, 2015.
URL : https://hal.archives-ouvertes.fr/pasteur-01415218

J. F. Okulicz, F. Boufassa, D. Costagliola, A. Ganesan, and O. Lambotte, Cancers in elite controllers: appropriate follow-up is essential, AIDS Lond Engl, vol.30, issue.11, pp.1852-1857, 201617.

I. Poizot-martin, H. Laroche, C. E. Cano, C. Nicolino-brunet, O. Zaegel-faucher et al., Cancer risk in HIV-infected patients: elite controllers are also concerned, AIDS Lond Engl, vol.32, issue.5, pp.673-678, 2018.

C. Lucero, B. Torres, A. León, M. Calvo, L. Leal et al., Rate and predictors of non-AIDS events in a cohort of HIV-infected patients with a CD4 T cell count above 500 cells/mm 3, AIDS Res Hum Retroviruses, vol.29, issue.8, pp.1161-1168, 2013.

B. Dominguez-molina, L. A. Rodriguez, C. Benito, J. M. Lopez-galindez, C. Garcia et al., Analysis of Non-AIDS-Defining Events in HIV Controllers, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.62, issue.10, pp.1304-1313, 2016.

T. A. Crowell, K. A. Gebo, J. N. Blankson, P. T. Korthuis, B. R. Yehia et al.,

, Hospitalization Rates and Reasons Among HIV Elite Controllers and Persons With Medically Controlled HIV Infection, J Infect Dis, vol.211, issue.11, pp.1692-702, 2015.

T. A. Crowell, A. Ganesan, S. A. Berry, R. G. Deiss, B. K. Agan et al., Hospitalizations among HIV controllers and persons with medically controlled HIV in the U.S. Military HIV Natural History Study, J Int AIDS Soc, vol.19, issue.1, p.20524, 2016.

K. A. Stafford, R. Tehrani, Z. Saadat, S. Ebadi, M. Redfield et al., Longterm follow-up of elite controllers: Higher risk of complications with HCV coinfection, no association with HIV disease progression, Medicine, vol.96, issue.26, p.7348, 2017.

N. Noël, M. Gominet, L. Meyer, F. Boufassa, and O. Lambotte, Cardiovascular events in the French ANRS HIV controller cohort, J Acquir Immune Defic Syndr, 1999.

P. Y. Hsue, P. W. Hunt, A. Schnell, S. C. Kalapus, R. Hoh et al., Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis, AIDS Lond Engl, vol.23, issue.9, pp.1059-67, 2009.

F. Pereyra, J. Lo, V. A. Triant, J. Wei, M. J. Buzon et al., Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers, AIDS Lond Engl, vol.26, issue.18, pp.2409-2421, 2012.

A. D. Nordell, M. Mckenna, Á. H. Borges, D. Duprez, J. Neuhaus et al., Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation, J Am Heart Assoc, vol.3, issue.3, p.844, 2014.

P. W. Hunt, J. Brenchley, E. Sinclair, J. M. Mccune, M. Roland et al., Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy, J Infect Dis, vol.197, issue.1, pp.126-159, 2008.

F. Pereyra, S. Palmer, T. Miura, B. L. Block, A. Wiegand et al., Persistent lowlevel viremia in HIV-1 elite controllers and relationship to immunologic parameters, J Infect Dis, vol.200, issue.6, pp.984-90, 2009.

J. M. Brenchley, D. A. Price, T. W. Schacker, T. E. Asher, G. Silvestri et al., Microbial translocation is a cause of systemic immune activation in chronic HIV infection, Nat Med, vol.12, issue.12, pp.1365-71, 2006.

N. Noel, F. Boufassa, C. Lécuroux, A. Saez-cirion, C. Bourgeois et al.,

, Elevated IP10 levels are associated with immune activation and low CD4 + T-cell counts in HIV controller patients, AIDS Lond Engl, vol.28, issue.4, pp.467-76, 2014.

S. Krishnan, E. Wilson, V. Sheikh, A. Rupert, D. Mendoza et al., Evidence for innate immune system activation in HIV type 1-infected elite controllers, J Infect Dis, vol.209, issue.6, pp.931-940, 2014.

M. Pernas, L. Tarancón-diez, E. Rodríguez-gallego, J. Gómez, J. G. Prado et al.,

, Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection, J Virol, 2017.

N. A. Taborda, M. T. Rugeles, and C. J. Montoya, Spontaneous control of HIV replication, but not HAART-induced viral suppression, is associated with lower activation of immune cells, J Acquir Immune Defic Syndr, vol.66, issue.4, pp.365-374, 1999.

N. A. Taborda, S. M. Gonzalez, L. A. Correa, C. J. Montoya, and M. T. Rugeles, Spontaneous HIV Controllers Exhibit Preserved Immune Parameters in Peripheral Blood and Gastrointestinal Mucosa, J Acquir Immune Defic Syndr, vol.70, issue.2, pp.115-136, 1999.

A. Bansal, S. Sterrett, N. Erdmann, A. O. Westfall, J. Dionne-odom et al., Normal T-cell activation in elite controllers with preserved CD4+ T-cell counts, AIDS Lond Engl, vol.29, issue.17, pp.2245-54, 2015.

F. H. Côrtes, C. P. Passaes, G. Bello, S. L. Teixeira, C. Vorsatz et al., HIV controllers with different viral load cutoff levels have distinct virologic and immunologic profiles, J Acquir Immune Defic Syndr, vol.68, issue.4, pp.377-85, 1999.

J. F. Okulicz, G. A. Grandits, A. C. Weintrob, M. L. Landrum, A. Ganesan et al.,

, CD4 T cell count reconstitution in HIV controllers after highly active antiretroviral therapy, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.50, issue.8, pp.1187-91, 2010.

A. R. Sedaghat, D. A. Rastegar, O. 'connell, K. A. Dinoso, J. B. Wilke et al., T cell dynamics and the response to HAART in a cohort of HIV-1-infected elite suppressors, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.49, issue.11, pp.1763-1769, 2009.

T. Chun, S. Justement, J. Murray, D. Kim, C. J. Blazkova et al., Effect of antiretroviral therapy on HIV reservoirs in elite controllers, J Infect Dis, vol.208, issue.9, pp.1443-1450, 2013.

C. J. Kim, C. Kovacs, T. Chun, G. Kandel, B. Osborne et al., Antiretroviral therapy in HIV-infected elite controllers: impact on gut immunology, microbial translocation, and biomarkers of serious non-AIDS conditions, J Acquir Immune Defic Syndr, vol.67, issue.5, pp.514-522, 1999.

H. Hatano, S. A. Yukl, A. L. Ferre, E. H. Graf, M. Somsouk et al., Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers, PLoS Pathog, vol.9, issue.10, p.1003691, 2013.

F. Boufassa, J. Lechenadec, L. Meyer, D. Costagliola, P. W. Hunt et al., Blunted response to combination antiretroviral therapy in HIV elite controllers: an international HIV controller collaboration, PloS One, vol.9, issue.1, p.85516, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01344809

J. Z. Li, F. P. Segal, R. J. Bosch, C. M. Lalama, C. Roberts-toler et al., ART reduces T cell activation and immune exhaustion markers in HIV controllers, Clin Infect Dis Off Publ Infect Dis Soc Am, 2019.

E. Canouï, C. Lécuroux, V. Avettand-fenoël, M. Gousset, C. Rouzioux et al., A Subset of Extreme Human Immunodeficiency Virus (HIV) Controllers Is Characterized by a Small HIV Blood Reservoir and a Weak T-Cell Activation Level, Open Forum Infect Dis, vol.4, issue.2, p.64, 2017.

Y. Madec, F. Boufassa, V. Avettand-fenoel, S. Hendou, A. Melard et al., Early control of HIV-1 infection in long-term nonprogressors followed since diagnosis in the ANRS SEROCO/HEMOCO cohort, J Acquir Immune Defic Syndr, vol.50, issue.1, pp.19-26, 1999.

D. Mendoza, S. A. Johnson, B. A. Peterson, V. Natarajan, M. Salgado et al.,

, Comprehensive analysis of unique cases with extraordinary control over HIV replication, Blood, vol.119, issue.20, pp.4645-55, 2012.

V. Avettand-fenoel, T. Bayan, E. Gardiennet, F. Boufassa, P. Lopez et al., Dynamics in HIV-DNA levels over time in HIV controllers, J Int AIDS Soc, vol.22, issue.1, p.25221, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02024787

G. M. Laird, E. E. Eisele, S. A. Rabi, J. Lai, S. Chioma et al., Rapid Quantification of the Latent Reservoir for HIV-1 Using a Viral Outgrowth Assay, PLoS Pathog, vol.9, issue.5, 2013.

B. S. Taylor, H. Tieu, J. Jones, and T. J. Wilkin, CROI 2019: advances in antiretroviral therapy, Top Antivir Med, vol.27, issue.1, pp.50-68, 2019.

S. Piconi, S. Parisotto, G. Rizzardini, S. Passerini, R. Terzi et al.,

, Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders, Blood, vol.118, issue.12, pp.3263-72, 2011.

L. Calza, V. Colangeli, E. Magistrelli, I. Contadini, I. Bon et al., Significant Decrease in Plasma Levels of D-Dimer, Interleukin-8, and Interleukin-12 After a 12-Month Treatment with Rosuvastatin in HIV-Infected Patients Under Antiretroviral Therapy, AIDS Res Hum Retroviruses, vol.33, issue.2, pp.126-158, 2017.